Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-58 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 |
filingDate |
2003-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5677228d3acc02af6446653106d25b04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf3002984c6d1203f02f06c76473de6 |
publicationDate |
2004-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2004143016-A1 |
titleOfInvention |
Catalytic antioxidants and methods of use |
abstract |
The invention provides small molecules that act as catalytic antioxidants and methods of use thereof. The compounds can repeatedly bind and destroy reactive oxygen species by serving as substates for enzymes of the methionine sulfoxide reductase (Msr) class. Some embodiments of the catalytic antioxidant compounds are derived from drugs with anti-inflammatory activity due to inhibition of cyclooxygenase enzymes. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8022246-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006235080-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009042980-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357720-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006102439-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008108825-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010069331-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603985-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8258181-B2 |
priorityDate |
2002-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |